AML patients with CEBPalpha mutations mostly retain identical mutant patterns but frequently change in allelic distribution at relapse: a comparative analysis on paired diagnosis and relapse samples
- PMID: 16453003
- DOI: 10.1038/sj.leu.2404124
AML patients with CEBPalpha mutations mostly retain identical mutant patterns but frequently change in allelic distribution at relapse: a comparative analysis on paired diagnosis and relapse samples
Abstract
The roles of CEBPalpha mutations and its cooperating mutations in the relapse of acute myeloid leukemia (AML) are not clear. CEBPalpha mutations were analyzed on 149 patients with de novo AML at both diagnosis and relapse. Twenty-two patients (14.8%) had the mutations at diagnosis, two patients had N-terminal nonsense mutations alone, one had homozygous inframe duplication at the bZIP domain, and 19 patients had both N-terminal and bZIP mutations. Twenty patients relapsed with identical mutant patterns, two lost CEBPalpha mutations and none acquired the mutations at relapse. Cloning analysis showed that the N-terminal and C-terminal mutations occurred on separate cloned alleles and also on the same alleles in most of the diagnosis and relapse samples. Losing one of the two or more mutations on the same allele or acquiring the other mutation on the allele original carrying single mutation were observed not infrequently in the paired samples analyzed. Seven patients with CEBPalpha mutations had cooperating mutations with FLT3/ITD, FLT3/TKD or N-ras but not K-ras mutations. Our study showed that 91% of de novo AML harboring CEBPalpha mutations at diagnosis retained the identical mutant patterns but frequently changed in the allelic distribution at relapse.
Similar articles
-
Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.Clin Cancer Res. 2005 Mar 1;11(5):1821-6. doi: 10.1158/1078-0432.CCR-04-1932. Clin Cancer Res. 2005. PMID: 15756005
-
CEBPalpha mutations in childhood acute myeloid leukemia.Leukemia. 2005 Mar;19(3):410-4. doi: 10.1038/sj.leu.2403608. Leukemia. 2005. PMID: 15618961 Clinical Trial.
-
Cooperating mutations of receptor tyrosine kinases and Ras genes in childhood core-binding factor acute myeloid leukemia and a comparative analysis on paired diagnosis and relapse samples.Leukemia. 2008 Feb;22(2):303-7. doi: 10.1038/sj.leu.2404995. Epub 2007 Oct 25. Leukemia. 2008. PMID: 17960171
-
Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia.Leukemia. 2004 Mar;18(3):466-75. doi: 10.1038/sj.leu.2403274. Leukemia. 2004. PMID: 14737077
-
Genetic aberrations involved in relapse of pediatric acute myeloid leukemia: A literature review.Asia Pac J Clin Oncol. 2021 Oct;17(5):e135-e141. doi: 10.1111/ajco.13367. Epub 2020 Jun 23. Asia Pac J Clin Oncol. 2021. PMID: 32573082 Review.
Cited by
-
Characteristic immunophenotype and gene co-mutational status orchestrate to optimize the prognosis of CEBPA mutant acute myeloid leukemia.Blood Cancer J. 2023 May 5;13(1):70. doi: 10.1038/s41408-023-00838-2. Blood Cancer J. 2023. PMID: 37147303 Free PMC article. No abstract available.
-
C/EBPα deregulation as a paradigm for leukemogenesis.Leukemia. 2017 Nov;31(11):2279-2285. doi: 10.1038/leu.2017.229. Epub 2017 Jul 19. Leukemia. 2017. PMID: 28720765 Free PMC article. Review.
-
Molecular mechanisms for stemness maintenance of acute myeloid leukemia stem cells.Blood Sci. 2019 Sep 17;1(1):77-83. doi: 10.1097/BS9.0000000000000020. eCollection 2019 Aug. Blood Sci. 2019. PMID: 35402786 Free PMC article.
-
FLT3-internal tandem duplication and age are the major prognostic factors in patients with relapsed acute myeloid leukemia with normal karyotype.Haematologica. 2011 May;96(5):681-6. doi: 10.3324/haematol.2010.034074. Epub 2011 Jan 17. Haematologica. 2011. PMID: 21242187 Free PMC article. Clinical Trial.
-
Acute Myeloid Leukemia With CEBPA Mutations: Current Progress and Future Directions.Front Oncol. 2022 Feb 1;12:806137. doi: 10.3389/fonc.2022.806137. eCollection 2022. Front Oncol. 2022. PMID: 35178345 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous